Many Teens Using Tobacco Don't Self-Identify As Users

Share this content:
Many Teens Using Tobacco Don't Self-Identify As Users
Many Teens Using Tobacco Don't Self-Identify As Users

THURSDAY, March 15, 2018 (HealthDay News) -- Many adolescent users of one or more specific tobacco product type do not self-identify as tobacco users, according to a study published online March 12 in Pediatrics.

Israel Agaku, D.M.D., M.P.H., Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined tobacco-related self-identity and risk perceptions among 20,675 U.S. sixth to 12th graders. Adolescents were classified as not self-identifying as tobacco users if they reported past 30-day use of a specific tobacco product or two or more products, but denied having used "any tobacco product" in the past 30 days.

Those denying having used any tobacco products included single-product users of roll-your-own and/or pipe tobacco (82.2 percent), electronic cigarettes (59.7 percent), cigars (56.6 percent), and cigarettes (26.5 percent). The researchers found that the odds of denying any tobacco product use were increased among those without versus those with symptoms of nicotine dependence (adjusted odds ratio, 2.16) and for those who access their tobacco products via social sources versus those who bought them (adjusted odds ratio, 3.81). Of those who believed "all tobacco products" were harmful, single product users of e-cigarettes, hookah, smokeless tobacco, and cigarettes believed their own product was not harmful (74.6, 56.0, 41.8, and 15.5 percent, respectively).

"Increasing the sensitivity of questions used to assess youth tobacco use in surveys and clinical settings can mitigate nondisclosure or underreporting of true tobacco use status," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »